Patients were less insulin-resistant than reported (HOMA-IR: 2.6 ± 1.8; or 2.2 ± 1.3 if those on insulin treatment were excluded) which may be related to co-existing metformin use [41]. This evidence concerns the gene INS and Insulin resistance.